• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两阶段临床试验中响应比例的均方误差降低估计量。

An MSE-reduced estimator for the response proportion in a two-stage clinical trial.

作者信息

Li Qizhai

机构信息

Key Laboratory of Systems and Control, Academy of Mathematics and Systems Science, CAS, Zhongguancun, Beijing, China.

出版信息

Pharm Stat. 2011 May-Jun;10(3):277-9. doi: 10.1002/pst.414. Epub 2010 Feb 5.

DOI:10.1002/pst.414
PMID:20140880
Abstract

Two-stage design is very useful in clinical trials for evaluating the validity of a specific treatment regimen. When the second stage is allowed to continue, the method used to estimate the response rate based on the results of both stages is critical for the subsequent design. The often-used sample proportion has an evident upward bias. However, the maximum likelihood estimator or the moment estimator tends to underestimate the response rate. A mean-square error weighted estimator is considered here; its performance is thoroughly investigated via Simon's optimal and minimax designs and Shuster's design. Compared with the sample proportion, the proposed method has a smaller bias, and compared with the maximum likelihood estimator, the proposed method has a smaller mean-square error.

摘要

两阶段设计在评估特定治疗方案有效性的临床试验中非常有用。当允许第二阶段继续进行时,基于两个阶段的结果来估计缓解率所使用的方法对于后续设计至关重要。常用的样本比例存在明显的向上偏差。然而,最大似然估计器或矩估计器往往会低估缓解率。本文考虑了一种均方误差加权估计器;通过西蒙的最优和极小极大设计以及舒斯特的设计对其性能进行了全面研究。与样本比例相比,所提出的方法偏差较小,与最大似然估计器相比,所提出的方法均方误差较小。

相似文献

1
An MSE-reduced estimator for the response proportion in a two-stage clinical trial.两阶段临床试验中响应比例的均方误差降低估计量。
Pharm Stat. 2011 May-Jun;10(3):277-9. doi: 10.1002/pst.414. Epub 2010 Feb 5.
2
Assessment of the Gould-Shih procedure for sample size re-estimation.用于样本量重新估计的古尔德-施氏程序评估。
Pharm Stat. 2007 Jan-Mar;6(1):53-65. doi: 10.1002/pst.244.
3
A simple and efficient bias-reduced estimator of response probability following a group sequential phase II trial.一种用于成组序贯II期试验后反应概率的简单有效且偏差减小的估计量。
J Biopharm Stat. 2005;15(5):773-81. doi: 10.1081/BIP-200067771.
4
Balanced two-stage designs for phase II clinical trials.用于II期临床试验的平衡两阶段设计
Clin Trials. 2007;4(5):514-24. doi: 10.1177/1740774507084102.
5
Interval estimation of binomial proportion in clinical trials with a two-stage design.两阶段设计的临床试验中二元比例的区间估计。
Stat Med. 2008 Jan 15;27(1):15-35. doi: 10.1002/sim.2930.
6
A new adaptive design based on Simon's two-stage optimal design for phase II clinical trials.基于 Simon 两阶段最优设计的新型适应性设计用于 II 期临床试验。
Contemp Clin Trials. 2012 Nov;33(6):1255-60. doi: 10.1016/j.cct.2012.07.003. Epub 2012 Jul 6.
7
Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.在两阶段成组序贯设计中,当试验提前终止时,在假设渐近正态性的情况下使用先验信息进行条件估计。
Pharm Stat. 2018 Sep;17(5):400-413. doi: 10.1002/pst.1859. Epub 2018 Apr 23.
8
Optimal and minimax three-stage designs for phase II oncology clinical trials.肿瘤学II期临床试验的最优和极小极大三阶段设计。
Contemp Clin Trials. 2008 Jan;29(1):32-41. doi: 10.1016/j.cct.2007.04.008. Epub 2007 May 6.
9
Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.非随机临床试验中混合分布的加权非参数最大似然估计
Stat Med. 2007 Dec 20;26(29):5303-19. doi: 10.1002/sim.2914.
10
Minimax and admissible adaptive two-stage designs in phase II clinical trials.最小化极大和可接受的适应性两阶段设计在 II 期临床试验中。
BMC Med Res Methodol. 2016 Aug 2;16:90. doi: 10.1186/s12874-016-0194-3.

引用本文的文献

1
Point estimation for adaptive trial designs I: A methodological review.自适应试验设计的点估计 I:方法学综述。
Stat Med. 2023 Jan 30;42(2):122-145. doi: 10.1002/sim.9605. Epub 2022 Nov 30.
2
What inference for two-stage phase II trials?两阶段 II 期临床试验的推断是什么?
BMC Med Res Methodol. 2012 Aug 6;12:117. doi: 10.1186/1471-2288-12-117.